|
It was reported, that prior to an unspecified procedure upon opening the sealed packaging of a cxi support catheter, the tip of the device fell apart.The device did not make contact with the patient.The procedure was completed using a different unspecified device.There were no adverse effects or the need for additional procedures reported for the patient due to this occurrence.
|
|
Summary of event: it was reported that prior to an unspecified procedure, upon opening the sealed packaging of a cxi support catheter, the tip of the device fell apart.The device did not make contact with the patient.The procedure was completed using a different unspecified device.There were no adverse effects or the need for additional procedures reported for the patient due to this occurrence.Investigation evaluation: reviews of the complaint history, device history record, drawing, instructions for use (ifu), manufacturing instructions, and quality control procedures were conducted during the investigation.The complaint device was not returned to cook for investigation.A document-based investigation evaluation was performed.Two related non-conformances were noted on subassembly lots; however, all affected product was scrapped, and there are 100% inspections in place to capture the non-conformance.There have been no additional complaints involving the complaint device lot or any subassembly lots.The product ifu states ¿supplied sterilized by ethylene oxide gas in peel-open packages.Intended for one-time use.Sterile if package is unopened and undamaged.Do not use the product if there is doubt as to whether the product is sterile.Store in a dark, dry, cool place.Avoid extended exposure to light.Upon removal from package, inspect the product to ensure no damage has occurred.¿ the information provided upon review of the dmr, dhr, and ifu suggests that there is evidence the device was manufactured out of specification; however, cook has concluded that this was an isolated event.Although two relevant non-conformances were noted on sub-assembly lots, all non-conforming product was scrapped, there are 100% inspections in place to capture this non-conformance, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, and no other lot-related complaints have been received from the field.Therefore, it was concluded that there is no evidence that additional non-conforming product exists in house or in the field.Cook has concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.Based on the information provided and the results of the investigation, cook has concluded that a manufacturing deficiency contributed to this event.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|